Cardio Diagnostics Holdings, Inc.
NASDAQ Global MarketTotal Valuation
Cardio Diagnostics Holdings, Inc. carries a market capitalization of 3.23M, placing it among publicly traded companies globally. Its enterprise value stands at -5.14M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 3.23M |
| Enterprise Value | -5.14M |
Share Statistics
Cardio Diagnostics Holdings, Inc. currently has 2.96M shares outstanding.
| Shares Outstanding | 2.96M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | 0.01 |
| P/TBV Ratio | 0.01 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Financial Position
Cardio Diagnostics Holdings, Inc. maintains a current ratio of 17.15, meaning it holds 17.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 4.98, indicating elevated leverage, while an interest coverage ratio of -494.68 demonstrates limited ability to service its debt obligations.
| Current Ratio | 17.15 |
| Quick Ratio | 15.56 |
| Debt / Equity | 4.98 |
| Debt / EBITDA | -0.06 |
| Interest Coverage | -494.68 |
Financial Efficiency
| Return on Equity (ROE) | -75.44 |
| Return on Assets (ROA) | -70.62 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
Cardio Diagnostics Holdings, Inc.'s stock has declined approximately -38.19095% over the past 52 weeks. The 50-day moving average sits at 0.01, while the 200-day moving average is 0.02.
| Beta (5Y) | N/A |
| 52-Week Price Change | -38.19095% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.02 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -6.08M, while operating income came in at -6.46M.
| Revenue | 14,450.00 |
| Gross Profit | N/A |
| Operating Income | -6.46M |
| Pretax Income | -6.47M |
| Net Income | -6.47M |
| EBITDA | -6.08M |
| EBIT | -6.46M |
| Earnings Per Share (EPS) | N/A |
Balance Sheet
Cardio Diagnostics Holdings, Inc. holds 5.59M in cash and equivalents against 369,698.00 in total debt, resulting in a net debt position of -5.52M. Total book value stands at 7.43M, with working capital of 5.80M providing operational flexibility.
| Cash & Cash Equivalents | 5.59M |
| Total Debt | 369,698.00 |
| Net Debt | -5.52M |
| Equity (Book Value) | 7.43M |
| Book Value Per Share | 2.51 |
| Working Capital | 5.80M |
Cash Flow
Cardio Diagnostics Holdings, Inc. produced -5.66M in operating cash flow over the past twelve months.
| Operating Cash Flow | -5.66M |
| Capital Expenditures | -446,663.00 |
| Free Cash Flow | -6.11M |
| FCF Per Share | N/A |
Margins
Cardio Diagnostics Holdings, Inc. operates with a gross margin of 100.00, reflecting its pricing power and cost economics. The operating margin of -44,690.68 and net profit margin of -44,771.83 provide insight into operational efficiency.
| Gross Margin | 100.00 |
| Operating Margin | -44,690.68 |
| Pretax Margin | -44,771.83 |
| Profit Margin | -44,771.83 |
| EBITDA Margin | -42,104.12 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -4,997.01 |
| FCF Yield | N/A |
Scores
Cardio Diagnostics Holdings, Inc. posts an Altman Z-Score of -8.52, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -8.52 |